{"id":1871,"date":"2018-08-17T09:33:01","date_gmt":"2018-08-17T09:33:01","guid":{"rendered":"http:\/\/lactusan.lactulose.org\/?p=1871"},"modified":"2018-10-26T07:50:44","modified_gmt":"2018-10-26T07:50:44","slug":"o-primenenii-laktusana-v-otdelenii-virusnyx-gepatitov","status":"publish","type":"post","link":"https:\/\/lactusan.com.ua\/en\/o-primenenii-laktusana-v-otdelenii-virusnyx-gepatitov\/","title":{"rendered":"Lactusan for viral hepatitis"},"content":{"rendered":"<div style=\"text-align: justify;\" align=\"justify\">Under observation were 38 children with viral hepatitis and gastropathology aged: from 0 to 3 years \u2014 5 children, from 4 to 7 \u2014 10 children, from 8 to 11 years \u2014 8 children, from 12 to 15 \u2014 14 children. Among the examined were 24 children with concomitant allergic diseases, including 8 with exacerbation of allergic dermatoses. Before treatment, stage I dysbacteriosis was diagnosed in 11 patients, stage II dysbacteriosis in 13 patients, and stage III dysbacteriosis in 14 patients. E. coli with hemolyzing properties (45%), citrobacter (20%), enterobacteria (20%), Klebsiella (15%), microbial associations (40%) were more often detected. Examination after the course of treatment showed an improvement in biocenosis indicators in 22 patients (57.9%), including those with grade II and III dysbacteriosis, an increase in the level of bifidobacteria to 109 in 18 out of 27 (66%) patients, a decrease in seeding of opportunistic flora in 13 (48% ), in 1 child - the disappearance of pathogenic E - Coli O 144. With dysbacteriosis of the 1st degree with a normal initial level of bifidobacteria, an improvement in the biocenosis was registered in 4 patients, which was expressed by the normalization of the number of Escherichia coli, lactic acid bacteria. In 12 (32%) patients there was no change.<\/div>\n<div style=\"text-align: justify;\" align=\"justify\">In 3 out of 8 children with exacerbation of allergic dermatosis, allergic manifestations subsided without additional prescription of sorbents and (or) antihistamines.<br \/>\nSide effects in the form of increased stools up to 2-3 times a day were observed in 4 patients, a tendency to flatulence in 2 (children under one year old). In 6 children with initial complaints of a tendency to constipation during treatment, daily bowel movements were observed.<\/div>\n<div style=\"text-align: justify;\" align=\"justify\"><strong>Thus, even with the appointment of the minimum dosage of syrup &quot;Lactusan&quot; in 58% cases, a positive effect is observed. It is likely that with increasing doses, better results can be expected.<\/strong><\/div>\n<div style=\"text-align: justify;\" align=\"justify\"><strong><br \/>\nThe advantages of the drug also include the possibility of using a relatively small course, the absence of negative organoleptic properties.<\/strong><\/div>\n<div style=\"text-align: justify;\" align=\"justify\"><strong><br \/>\nIt is also relevant to prescribe the drug to patients with a tendency to constipation.<\/strong><\/div>","protected":false},"excerpt":{"rendered":"<p>\u041f\u043e\u0434 \u043d\u0430\u0431\u043b\u044e\u0434\u0435\u043d\u0438\u0435\u043c \u043d\u0430\u0445\u043e\u0434\u0438\u043b\u0438\u0441\u044c 38 \u0434\u0435\u0442\u0435\u0439 \u0441 \u0432\u0438\u0440\u0443\u0441\u043d\u044b\u043c\u0438 \u0433\u0435\u043f\u0430\u0442\u0438\u0442\u0430\u043c\u0438 \u0438 \u0433\u0430\u0441\u0442\u0440\u043e\u043f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0435\u0439 \u0432 \u0432\u043e\u0437\u0440\u0430\u0441\u0442\u0435: \u043e\u0442 0 \u0434\u043e 3 \u043b\u0435\u0442 \u2014 5 \u0434\u0435\u0442\u0435\u0439, \u043e\u0442 4 \u0434\u043e 7 \u2014 10 \u0434\u0435\u0442\u0435\u0439, \u043e\u0442 8 \u0434\u043e 11 \u043b\u0435\u0442 \u2014 8 \u0434\u0435\u0442\u0435\u0439, \u043e\u0442 12 \u0434\u043e 15 \u2014 14 \u0434\u0435\u0442\u0435\u0439. \u0421\u0440\u0435\u0434\u0438 \u043e\u0431\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u043d\u044b\u0445 \u0431\u044b\u043b\u043e 24 \u0440\u0435\u0431\u0435\u043d\u043a\u0430 \u0441 \u0441\u043e\u043f\u0443\u0442\u0441\u0442\u0432\u0443\u044e\u0449\u0438\u043c\u0438 \u0430\u043b\u043b\u0435\u0440\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u043c\u0438 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f\u043c\u0438, \u0432 \u0442\u043e\u043c \u0447\u0438\u0441\u043b\u0435 8 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[233],"tags":[],"class_list":["post-1871","post","type-post","status-publish","format-standard","hentry","category-klinicheskie-issledovaniya"],"_links":{"self":[{"href":"https:\/\/lactusan.com.ua\/en\/wp-json\/wp\/v2\/posts\/1871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lactusan.com.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lactusan.com.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lactusan.com.ua\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lactusan.com.ua\/en\/wp-json\/wp\/v2\/comments?post=1871"}],"version-history":[{"count":2,"href":"https:\/\/lactusan.com.ua\/en\/wp-json\/wp\/v2\/posts\/1871\/revisions"}],"predecessor-version":[{"id":2697,"href":"https:\/\/lactusan.com.ua\/en\/wp-json\/wp\/v2\/posts\/1871\/revisions\/2697"}],"wp:attachment":[{"href":"https:\/\/lactusan.com.ua\/en\/wp-json\/wp\/v2\/media?parent=1871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lactusan.com.ua\/en\/wp-json\/wp\/v2\/categories?post=1871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lactusan.com.ua\/en\/wp-json\/wp\/v2\/tags?post=1871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}